BioCentury
ARTICLE | Clinical News

Xyzal Allergy 24HR regulatory update

February 9, 2017 9:52 PM UTC

Sanofi said FDA approved Xyzal Allergy 24HR levocetirizine for OTC use to treat symptoms associated with seasonal and year-round allergies. Sanofi expects Xyzal Allergy 24HR will be available in spri...

BCIQ Company Profiles

Sanofi

UCB S.A.

BCIQ Target Profiles

Histamine H1 receptor (HRH1)